Haemonetics

Haemonetics Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of Haemonetics (HAE) as of Oct 20, 2026 is 189.39. In the previous year, Days Inventory Outstanding (DIO) was 228.89 — a change of -17.26% (lower).

Days Inventory Outstanding

189.39

YoY

-17.26%

Last updated:

Days Inventory Outstanding (DIO) of Haemonetics is 2026 189.39 . Days Inventory Outstanding (DIO) of Haemonetics was 2025 228.89 . It decreases by -17.26% lower compared to the previous year.

The Haemonetics Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2019
128.96 USD
Jan 1, 2020
197.04 USD
Jan 1, 2021
266.40 USD
Jan 1, 2022
231.29 USD
Jan 1, 2023
173.46 USD
Jan 1, 2024
193.89 USD
Jan 1, 2025
228.89 USD
Jan 1, 2026
189.39 USD
The Haemonetics Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
189.39-17.26%
228.89+18.05%
193.89+11.78%
173.46-25.00%
231.29-13.18%
266.40+35.20%
197.04+52.79%
128.96+8.11%
119.29-6.23%
127.22-5.83%
135.10-16.54%
161.87+5.48%
153.46—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Haemonetics Stock analysis

What does Haemonetics do? Haemonetics Corp is a leading provider of blood processing and transfusion products. The company was founded in 1971 by Dr. Jack Latham to create a better solution for the storage and transfer of blood products. Since then, the company has become a major provider of products and services for the blood transfusion industry. Haemonetics' business model is focused on the development, manufacturing, and marketing of products and devices for blood transfusion. The company offers a wide range of products and services, including blood processing systems, blood collection and maintenance devices, software solutions, blood components, and related accessories. In recent years, Haemonetics has dedicated itself to diversifying its offerings. While still focusing on the blood transfusion industry, the company has also expanded into other areas, such as the treatment of patients with blood disorders and the development of devices for cell therapy. Haemonetics is divided into various business segments, including Blood Management Solutions, Diagnostic Solutions, and Haemonetics Software Solutions. The Blood Management Solutions segment includes a range of products, including blood collection and storage devices, centrifuges, and hematocrit systems. Diagnostic Solutions provides diagnostic tests for blood disorders, including tests for coagulation disorders and thrombophilia. Haemonetics Software Solutions offers software solutions for the blood transfusion industry, including systems for automated processing and storage of blood products, as well as systems for automatic inventory management. Haemonetics' products also include devices for freezing blood products and for processing blood components. These devices help ensure that blood products are stored at optimal temperatures and conditions to ensure their effectiveness and usability for the patient. Another important area of Haemonetics' business is the development of devices for cell therapy. The company works closely with research institutes and biotech companies to develop innovative technologies for cell therapy. This includes the development of devices for the isolation and purification of stem cells that can be used for the treatment of cancer and other diseases. Haemonetics Corp has made a name for itself in the blood transfusion industry and continues to focus on innovation and diversification to fully utilize the potential of the company and its products. With a wide range of products and services, a strong commitment to research and development, and an unwavering focus on the needs of patients and healthcare providers, Haemonetics is well positioned to continue growing and expanding in the future. Haemonetics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Haemonetics stock

Days Inventory Outstanding (DIO) of Haemonetics is 189.39 in 2026.

Days Inventory Outstanding (DIO) of Haemonetics changed from 228.89 to 189.39, representing a -17.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) Haemonetics since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s Haemonetics with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Haemonetics

All Key Metrics — Haemonetics